Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson’s disease

@article{Sriram2012ValproateAA,
  title={Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson’s disease},
  author={Ashok Sriram and Herbert E. Ward and A. Hassan and Sanjay S. Iyer and Kelly D. Foote and Ramon L. Rodriguez and Nikolaus R. McFarland and Michael S. Okun},
  journal={Journal of Neurology},
  year={2012},
  volume={260},
  pages={521-527}
}
  • Ashok Sriram, Herbert E. Ward, +5 authors Michael S. Okun
  • Published 2012
  • Medicine
  • Journal of Neurology
  • It has been previously well established that the use of dopaminergic agents in Parkinson’s disease may contribute to behavioral disturbances such as dopamine dysregulation syndrome (DDS), impulse control disorders (ICD), and punding. ICD and punding have been most commonly addressed by reducing dose or by discontinuing the use of a dopamine agonist. Treatment of DDS has proven more challenging, and to date there has been no standard approach. In this paper, we review a series of four patients… CONTINUE READING
    22 Citations
    Dopamine dysregulation syndrome in Parkinson’s disease: a systematic review of published cases
    • 36
    A systematic review of impulse control disorders in Parkinson's disease.
    • 68
    • PDF
    Treatment of psychiatric disturbances in hypokinetic movement disorders
    • 1
    Behavioral effects of levodopa
    • I. Beaulieu-Boire, A. Lang
    • Psychology, Medicine
    • Movement disorders : official journal of the Movement Disorder Society
    • 2015
    • 55
    Impulsive and compulsive behaviors in Parkinson's disease.
    • 16
    Neuropsychiatric Issues in Parkinson’s Disease
    • 54

    References

    SHOWING 1-10 OF 44 REFERENCES
    Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease.
    • 39
    Dopaminergic dysregulation syndrome in Parkinson's disease
    • 25
    Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.
    • 398
    • PDF
    Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease.
    • 118
    Addiction-Like Manifestations and Parkinson's Disease: A Large Single Center 9-Year Experience
    • 27
    Impulsive and Compulsive Behaviors in Parkinson’s Disease
    • 92
    • PDF
    The natural history of Parkinson's disease in the pre-levodopa and post-levodopa eras.
    • 95
    Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation
    • 208
    Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward
    • 53